Arrowhead Publishers is pleased to announce its 3rd Annual Translational Microbiome Conference is coming back to Boston on April 11-13, 2017.
From James Vitale, Marketing Program Director: Attend the Translational Microbiome Conference in Boston this April to learn how the microbiome is impacting the drug discovery industry.
Researchers at the University of Virginia School of Medicine have reversed depression symptoms in mice by feeding them Lactobacillus, a probiotic bacteria found in live-cultures yogurt.
News and Views: Timothy J. Colston Complex communities of microorganisms living in the gastrointestinal tracts of animal hosts are known to play critical roles in a variety of processes affecting host fitness including physiology, immunity, behaviour and development.
By Show-Ling Shyng: Glucose-dependent organs such as the brain are sustained through periods of fasting by glucose production in the liver, called hepatic gluconeogenesis. Normally, rising blood glucose levels homeostatically suppress gluconeogenesis.
Irun R. Cohen, Professor of Immunology, Emeritus, The Weizmann Institute of Science Abstract In October of 2015, the startup company ImmunArray announced the launch of a microarray platform – the iChip® – to profile repertoires of serum antibodies and autoantibodies.
By Dr. Bill Van Bonn, Vice President of Animal Health at Shedd Aquarium. Specializes in preventive medicine and clinical veterinary services for aquatic animals: What is a microbiome you ask? It’s the tiny living community that surrounds us all and is the subject of investigation by human and veterinary health care providers everywhere.
Minneapolis, MN – February 15, 2017 – Arrowhead Publishers is pleased to announce that a variety of expert panel discussions have been announced for its upcoming 3rd Annual Translational Microbiome Conference.
Post by William G. Nelson, MD, PhD, Editor-in-Chief, Cancer Today: Over the past few years, scientists have come to a deeper understanding of how microorganisms can cause chronic human diseases, based on the recognition that each human body contains at least 40 trillion microorganisms.
Insight from Philip Dubé, PhD: Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract caused by a variety of genetic and environmental factors.
Anthony L. Komaroff, MD, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, shares his viewpoint in JAMA. Published online December 22, 2016:
The second keynote presentation at Arrowhead Publishers’ 3rd Annual Translational Microbiome Conference will be given by Dr. Rita Colwell, Distinguished Professor at Johns Hopkins Bloomberg School of Public Health and founder of CosmosID.
Submitted by Philip Dubé, PhD: Research isolating the key factors impacting establishment of an individual gut microbiome has interesting implications for the future of microbiome therapeutics – and translatable mouse model research.
Submitted by James Vitale, Marketing Program Director: Jack Gilbert, the faculty director of The Microbiome Center and professor at the University of Chicago, has just been announced as the keynote speaker at Arrowhead Publishers’ 3rd Annual Translational Microbiome Conference.
Insight from Megan M. MacBride, PhD: Malaria is a serious global health hazard, with 214 million new cases worldwide in 2015 according to the World Health Organization.
Arrowhead Publishers has announced the preliminary speaking faculty for the 3rd Annual Translational Microbiome Conference. This conference, taking place April 11-13, 2017 in Boston, MA,
Do you work in the microbiome field? Do you have an innovative idea or piece of research that could benefit patients? Do you want to pitch to partners that can help you commercialise your idea? This is a unique opportunity to pitch your ideas to leading innovators,
November 3, 2016 | Bolger Center in Potomac, MD November 17, 2016 | Conference Chicago at University Center in Chicago, IL This complimentary symposium will bring together hundreds of academic and biopharmaceutical industry scientists and executives to discuss microbiome science and its translational applications.
Call for presenters and posters at Taconic’s Advancing Microbiome Research Symposium: Microbiome & Disease. Event is November 17th in Chicago, IL. Submission deadline is September 19th. Get more details here: Register Now!
Interest in the microbiome and its role in health and disease is a rapidly growing research focus for academic institutions, biotech and pharmaceutical companies.